Dyslexia is a learning disability in reading. People with dyslexia have trouble reading at a good pace and without mistakes. They may also have a hard time with reading comprehension, spelling, and writing. The global dyslexia market is expected to increase by USD 11 billion, at a compound annual growth rate (CAGR) of 6.7% from 2022 to 2028, according to the latest edition of the Global Dyslexia Market Report.
This industry report offers market estimates of the global market, followed by a detailed analysis of the category, type of dyslexia, end user, and region. The global market data on dyslexia can be segmented by category: treatment, diagnosis. According to the research, the treatment segment had the largest share in the global dyslexia market. Dyslexia market is further segmented by type of dyslexia: phonological dyslexia, surface dyslexia, others. In 2021, the phonological dyslexia segment made up the largest share of revenue generated by the dyslexia market. Based on end user, the dyslexia market is segmented into: specialty centers, home care, hospitals & clinics, others. On the basis of region, the dyslexia market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
The global dyslexia market is highly competitive. The key players in the dyslexia market include Eli Lilly and Company, GSK plc, Lingit AS, Lyfta Oy, Novartis AG, Pfizer Inc., Soli, Speechify Inc., Teva Pharmaceutical Industries Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Dyslexia Market
– Identify segments/areas to invest in over the forecast period in the Global Dyslexia Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 6.7% |
| Pages | 22 |
| Key Players | Eli Lilly and Company, GSK plc, Lingit AS, Lyfta Oy, Novartis AG, Pfizer Inc., Soli, Speechify Inc., Teva Pharmaceutical Industries Ltd. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
